← All trials
NCT00130065
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2003
- Primary completion
- Feb 1, 2006
- Completion date
- Feb 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 600
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Centers for Disease Control and Prevention (CDC)Lead sponsor
- Kenya Medical Research InstituteCollaborator
- Kenya Ministry of HealthCollaborator
- Government of KenyaOverall official - principal investigator
- Centers for Disease Control and Prevention (CDC)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.